A total of five products were added in the month from four different asset managers: iShares, T. Rowe Price, Comvest Partners and NB Alternatives.
CCR Monthly Approval Report – September 2024
October 1, 2024 by
Polar Capital, DigitalBridge and Thomas H. Lee Partners were the managers registering products in September 2024.
CCR Monthly Approval Report – August 2024
September 4, 2024 by
Janus Henderson, Fidelity, Lazard, Muzinich, HarbourVest, Kohlberg & Co, Nautic and PSG Equity were the fund sponsors gaining approval for new products in August.
CCR Monthly Approval Report – July 2024
August 8, 2024 by
A total of 19 products were added in the month from nine different asset managers: BNP Paribas, BNY Mellon, Fidelity, First Sentier, Franklin Templeton, LarrainVial, PIMCO, Summit Partners and UBS.
CCR Monthly Approval Report – June 2024
July 2, 2024 by
JPMorgan led with five ETFs, followed by Allianz, Bluebay, Comgest, Man and Morgan Stanley each with one mutual fund approved. Two alternative products also got the green light, one from Hollyport Capital and one from Rivean Capital.
CCR Monthly Approval Report – May 2024
June 3, 2024 by
BNP Paribas, Credicorp Capital, JP Morgan, Morgan Stanley, PIMCO, Theam Quant, Eurazeo and Kinderhook were the fund sponsors gaining approval for new products.
CCR Monthly Approval Report – April 2024
May 6, 2024 by
A total of 22 products were added in the month from six different asset managers: Aegon, Bradesco, Invesco, Moneda, Oaktree andTikehau.
CCR Monthly Approval Report – March 2024
April 5, 2024 by
A total of 11 products were added in the month from four different asset managers: iShares, Premier Miton, Robeco and InfraRed Capital Partners.
CCR Monthly Approval Report – February 2024
March 4, 2024 by
A total of five products were added in the month from five different asset managers: AllianceBernstein, Man, Pinebridge, Apollo, GI Partners, Monroe Capital and SLR CP.
CCR Monthly Approval Report – January 2024
February 6, 2024 by
Three mutual funds, one ETF and one alternative product gained CCR approval to kick off 2024. Sponsors gaining approval were UBS, Invesco and TrueBridge Capital Partners.
